Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > German customers of LABS...did they anticipate legalization

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 22, 2024 9:16pm

85 Views

Post# 35948410

German customers of LABS...did they anticipate legalization

coming and therefore started to BUILD INVENTORY....ie, hitting LABS with bigger orders for inventory build in Q4, 2023?

Also....LABS indicated they 'sold out' quicker than expected in the Austrailian market....were there bigger orders hitting LABS in Q4, 2023 as well?

LABS customers in Brazil....that is a wild card as is what orders did Avicanna hit LABS with in Q4, 2023 as well?

The data at the link has been collected on every trading of LABS since August 11, 2023....something has changed and for the betterment of patient longs.

LABS market change versus volume Aug 11, 2023 to Mar 22, 2024...ENJOY!!!